Applied Interest Income vs Net Income From Continuing Ops Analysis

APLT Stock

USD 0.54 0.01 1.89%

Applied Therapeutics financial indicator trend analysis is way more than just evaluating Applied Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Applied Therapeutics is a good investment. Please check the relationship between Applied Therapeutics Interest Income and its Net Income From Continuing Ops accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.

Interest Income vs Net Income From Continuing Ops

Interest Income vs Net Income From Continuing Ops Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Applied Therapeutics Interest Income account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Applied Therapeutics' Interest Income and Net Income From Continuing Ops is -0.51. Overlapping area represents the amount of variation of Interest Income that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Applied Therapeutics, assuming nothing else is changed. The correlation between historical values of Applied Therapeutics' Interest Income and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Income of Applied Therapeutics are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Interest Income i.e., Applied Therapeutics' Interest Income and Net Income From Continuing Ops go up and down completely randomly.

Correlation Coefficient

-0.51

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.

Net Income From Continuing Ops

Most indicators from Applied Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Applied Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.Selling General Administrative is likely to drop to about 21.9 M in 2025. Issuance Of Capital Stock is likely to drop to about 69.8 M in 2025

Applied Therapeutics fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Capital Lease Obligations	Property Plant And Equipment Gross	Net Receivables	Non Current Liabilities Other
Total Assets		0.56	0.61	0.67	0.9	-0.94	-0.69	0.5	0.94	1.0	0.52	-0.81	0.88	0.87	0.74	0.58	0.67	1.0	0.6	-0.62	-0.58	0.51	-0.58	-0.52	-0.35	-0.59
Other Current Liab	0.56		0.99	-0.24	0.78	-0.74	-0.93	0.02	0.71	0.56	1.0	-0.62	0.84	0.53	0.94	1.0	-0.23	0.56	-0.32	-0.9	-0.97	-0.32	-0.97	-0.98	-0.88	-0.72
Total Current Liabilities	0.61	0.99		-0.17	0.81	-0.77	-0.95	0.15	0.74	0.61	0.99	-0.68	0.87	0.62	0.96	1.0	-0.17	0.62	-0.26	-0.91	-0.98	-0.3	-0.97	-0.98	-0.87	-0.76
Total Stockholder Equity	0.67	-0.24	-0.17		0.35	-0.45	0.04	0.5	0.46	0.67	-0.28	-0.38	0.27	0.5	0.02	-0.22	1.0	0.66	0.99	0.11	0.21	0.92	0.19	0.28	0.4	-0.01
Net Tangible Assets	0.9	0.78	0.81	0.35		-0.89	-0.88	0.37	0.87	0.89	0.75	-0.75	0.98	0.86	0.91	0.79	0.36	0.9	0.27	-0.83	-0.81	0.19	-0.82	-0.77	-0.66	-0.76
Net Debt	-0.94	-0.74	-0.77	-0.45	-0.89		0.8	-0.35	-0.98	-0.95	-0.7	0.81	-0.9	-0.76	-0.85	-0.74	-0.46	-0.95	-0.37	0.72	0.73	-0.35	0.73	0.69	0.48	0.65
Retained Earnings	-0.69	-0.93	-0.95	0.04	-0.88	0.8		-0.28	-0.79	-0.68	-0.92	0.75	-0.94	-0.73	-0.98	-0.93	0.03	-0.7	0.13	0.98	0.98	0.19	0.98	0.96	0.89	0.89
Accounts Payable	0.5	0.02	0.15	0.5	0.37	-0.35	-0.28		0.36	0.46	0.04	-0.57	0.38	0.76	0.26	0.1	0.5	0.5	0.45	-0.23	-0.14	0.22	-0.16	-0.12	-0.01	-0.47
Cash	0.94	0.71	0.74	0.46	0.87	-0.98	-0.79	0.36		0.95	0.68	-0.81	0.88	0.76	0.83	0.71	0.46	0.94	0.38	-0.73	-0.71	0.35	-0.71	-0.67	-0.49	-0.64
Cash And Short Term Investments	1.0	0.56	0.61	0.67	0.89	-0.95	-0.68	0.46	0.95		0.52	-0.79	0.87	0.84	0.73	0.57	0.67	1.0	0.6	-0.61	-0.57	0.54	-0.58	-0.51	-0.34	-0.57
Common Stock Shares Outstanding	0.52	1.0	0.99	-0.28	0.75	-0.7	-0.92	0.04	0.68	0.52		-0.6	0.81	0.52	0.93	1.0	-0.28	0.53	-0.37	-0.89	-0.97	-0.37	-0.96	-0.98	-0.88	-0.72
Non Current Liabilities Total	-0.81	-0.62	-0.68	-0.38	-0.75	0.81	0.75	-0.57	-0.81	-0.79	-0.6		-0.8	-0.86	-0.76	-0.63	-0.39	-0.81	-0.28	0.7	0.66	-0.09	0.67	0.63	0.56	0.66
Capital Surpluse	0.88	0.84	0.87	0.27	0.98	-0.9	-0.94	0.38	0.88	0.87	0.81	-0.8		0.86	0.96	0.85	0.28	0.88	0.18	-0.9	-0.88	0.1	-0.89	-0.84	-0.73	-0.84
Other Current Assets	0.87	0.53	0.62	0.5	0.86	-0.76	-0.73	0.76	0.76	0.84	0.52	-0.86	0.86		0.73	0.58	0.51	0.86	0.42	-0.67	-0.61	0.2	-0.62	-0.57	-0.48	-0.71
Other Stockholder Equity	0.74	0.94	0.96	0.02	0.91	-0.85	-0.98	0.26	0.83	0.73	0.93	-0.76	0.96	0.73		0.95	0.03	0.74	-0.07	-0.96	-0.97	-0.12	-0.97	-0.95	-0.84	-0.87
Total Liab	0.58	1.0	1.0	-0.22	0.79	-0.74	-0.93	0.1	0.71	0.57	1.0	-0.63	0.85	0.58	0.95		-0.22	0.58	-0.31	-0.9	-0.98	-0.33	-0.97	-0.98	-0.88	-0.75
Net Invested Capital	0.67	-0.23	-0.17	1.0	0.36	-0.46	0.03	0.5	0.46	0.67	-0.28	-0.39	0.28	0.51	0.03	-0.22		0.67	0.99	0.1	0.2	0.92	0.18	0.27	0.39	-0.02
Total Current Assets	1.0	0.56	0.62	0.66	0.9	-0.95	-0.7	0.5	0.94	1.0	0.53	-0.81	0.88	0.86	0.74	0.58	0.67		0.59	-0.62	-0.58	0.51	-0.59	-0.53	-0.35	-0.59
Net Working Capital	0.6	-0.32	-0.26	0.99	0.27	-0.37	0.13	0.45	0.38	0.6	-0.37	-0.28	0.18	0.42	-0.07	-0.31	0.99	0.59		0.2	0.3	0.94	0.28	0.36	0.48	0.07
Short Long Term Debt Total	-0.62	-0.9	-0.91	0.11	-0.83	0.72	0.98	-0.23	-0.73	-0.61	-0.89	0.7	-0.9	-0.67	-0.96	-0.9	0.1	-0.62	0.2		0.97	0.25	0.98	0.96	0.92	0.91
Property Plant And Equipment Net	-0.58	-0.97	-0.98	0.21	-0.81	0.73	0.98	-0.14	-0.71	-0.57	-0.97	0.66	-0.88	-0.61	-0.97	-0.98	0.2	-0.58	0.3	0.97		0.33	1.0	1.0	0.92	0.85
Current Deferred Revenue	0.51	-0.32	-0.3	0.92	0.19	-0.35	0.19	0.22	0.35	0.54	-0.37	-0.09	0.1	0.2	-0.12	-0.33	0.92	0.51	0.94	0.25	0.33		0.32	0.39	0.55	0.14
Capital Lease Obligations	-0.58	-0.97	-0.97	0.19	-0.82	0.73	0.98	-0.16	-0.71	-0.58	-0.96	0.67	-0.89	-0.62	-0.97	-0.97	0.18	-0.59	0.28	0.98	1.0	0.32		0.99	0.92	0.87
Property Plant And Equipment Gross	-0.52	-0.98	-0.98	0.28	-0.77	0.69	0.96	-0.12	-0.67	-0.51	-0.98	0.63	-0.84	-0.57	-0.95	-0.98	0.27	-0.53	0.36	0.96	1.0	0.39	0.99		0.93	0.83
Net Receivables	-0.35	-0.88	-0.87	0.4	-0.66	0.48	0.89	-0.01	-0.49	-0.34	-0.88	0.56	-0.73	-0.48	-0.84	-0.88	0.39	-0.35	0.48	0.92	0.92	0.55	0.92	0.93		0.74
Non Current Liabilities Other	-0.59	-0.72	-0.76	-0.01	-0.76	0.65	0.89	-0.47	-0.64	-0.57	-0.72	0.66	-0.84	-0.71	-0.87	-0.75	-0.02	-0.59	0.07	0.91	0.85	0.14	0.87	0.83	0.74

Click cells to compare fundamentals

Applied Therapeutics Account Relationship Matchups

Applied Therapeutics fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	104.5M	89.9M	38.4M	54.8M	63.1M	56.5M
Other Current Liab	19.8M	16.1M	27.9M	68.0M	78.2M	82.2M
Total Current Liabilities	21.2M	26.5M	33.4M	71.2M	81.9M	86.0M
Total Stockholder Equity	81.9M	62.5M	4.1M	(17.1M)	(15.4M)	(14.7M)
Net Tangible Assets	(19.6M)	32.6M	81.9M	62.5M	71.9M	75.5M
Net Debt	(55.7M)	(52.6M)	(15.8M)	(49.1M)	(44.2M)	(46.4M)
Retained Earnings	(160.7M)	(266.3M)	(348.8M)	(468.6M)	(421.7M)	(400.6M)
Accounts Payable	640K	9.5M	4.5M	1.7M	2.0M	1.9M
Cash	57.5M	53.9M	16.7M	49.9M	57.4M	34.4M
Non Current Assets Total	1.9M	1.5M	1.1M	447K	514.1K	488.3K
Other Assets	199K	1.9M	200K	1.0	1.15	1.09
Cash And Short Term Investments	96.8M	80.8M	30.6M	49.9M	57.4M	50.1M
Common Stock Shares Outstanding	22.0M	25.6M	37.8M	84.2M	96.9M	101.7M
Liabilities And Stockholders Equity	104.5M	89.9M	38.4M	54.8M	63.1M	56.5M
Non Current Liabilities Total	1.3M	891K	878K	797K	717.3K	1.4M
Other Current Assets	5.3M	7.0M	6.5M	4.2M	4.8M	5.0M
Other Stockholder Equity	242.8M	329.0M	352.8M	451.4M	519.1M	545.1M
Total Liab	22.6M	27.4M	34.3M	72.0M	82.8M	86.9M
Net Invested Capital	83.0M	63.3M	5.1M	(16.8M)	(15.2M)	(14.4M)
Total Current Assets	102.6M	88.4M	37.3M	54.4M	62.5M	55.4M
Accumulated Other Comprehensive Income	(2K)	(112K)	(107K)	51K	45.9K	48.2K
Net Working Capital	81.4M	61.9M	3.9M	(16.8M)	(15.1M)	(14.4M)
Short Term Debt	812K	884K	954K	739K	849.9K	588.5K
Common Stock	2K	3K	5K	8K	9.2K	9.7K
Capital Stock	2K	3K	5K	8K	9.2K	9.7K
Short Long Term Debt Total	1.7M	1.3M	891K	777K	699.3K	1.1M
Property Plant And Equipment Net	1.9M	1.5M	1.1M	447K	402.3K	382.2K
Capital Lease Obligations	1.7M	1.3M	891K	467K	420.3K	399.3K
Property Plant And Equipment Gross	1.9M	1.5M	1.1M	447K	402.3K	382.2K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Applied Stock Analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC